Cargando…
Therapeutic Potential of Circular RNAs in Osteosarcoma
Osteosarcoma is the most common malignant bone tumor in children and adolescents. Multiagent chemotherapy, together with surgical removal of all detectable lesions, has improved the long-term survival rate to 65–70% in patients with localized osteosarcoma and to 25–30% in patients with metastatic os...
Autores principales: | Wan, Ben, Hu, Hao, Wang, Renxian, Liu, Weifeng, Chen, Dafu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174900/ https://www.ncbi.nlm.nih.gov/pubmed/32351876 http://dx.doi.org/10.3389/fonc.2020.00370 |
Ejemplares similares
-
Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity
por: Wan, Ben, et al.
Publicado: (2021) -
Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma
por: Chen, Dafu, et al.
Publicado: (2023) -
Circular RNAs and Their Role in Exosomes
por: Han, Zeping, et al.
Publicado: (2022) -
Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma
por: Wang, Renxian, et al.
Publicado: (2023) -
Progress of research into circular RNAs in urinary neoplasms
por: Wan, Bangbei, et al.
Publicado: (2020)